Renata PLC (DSE:RENATA)
Bangladesh · Delayed Price · Currency is BDT 449.10
+0.20 (0.04%)
At close: Sep 24, 2026
Renata Market Cap
Renata has a market cap or net worth of 51.51 billion as of September 25, 2026. Its market cap has decreased by -6.59% in one year.
Market Cap
51.51B
Enterprise Value
69.39B
Revenue
44.93B
Ranking
n/a
PE Ratio
18.86
Stock Price
449.10
ChartMarket Cap Chart
Since June 2, 2003, Renata's market cap has increased from 320.77M to 51.51B, an increase of 15,958.21%. That is a compound annual growth rate of 24.32%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 24, 2026 | 51.51B | 14.62% |
| Dec 30, 2025 | 44.94B | -38.31% |
| Dec 30, 2024 | 72.84B | -47.85% |
| Dec 27, 2023 | 139.69B | - |
| Dec 29, 2022 | 139.69B | -0.67% |
| Dec 30, 2021 | 140.64B | 30.38% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Square Pharmaceuticals PLC. | 191.47B |
| Beximco Pharmaceuticals PLC. | 66.38B |
| Unilever Consumer Care | 38.27B |
| Beacon Pharmaceuticals | 23.40B |
| The ACME Laboratories | 16.57B |
| Asiatic Laboratories | 12.90B |
| The IBN SINA Pharmaceutical Industry | 9.85B |
| Navana Pharmaceuticals | 6.86B |